spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  brain metastases 

 HSMN NewsFeed - 14 Jan 2026
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
Devices Neurosurgery Oncology
 HSMN NewsFeed - 15 Jul 2025
GT Medical Technologies Completes Final Close of Company's Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors
Devices Neurosurgery Oncology Venture Capital
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jul 2024
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Feb 2024
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Nov 2023
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Oct 2022
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife(R) System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
Devices Reimbursement
 HSMN NewsFeed - 20 Jul 2022
Nuvalent Announces Leadership Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2022
Accuray CyberKnife(R) System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications
Devices Oncology Neurosurgery
 HSMN NewsFeed - 2 Feb 2022
Bexion Pharmaceuticals Announces Leadership Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2021
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
Devices Oncology FDA
 HSMN NewsFeed - 8 Dec 2021
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Nov 2021
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Aug 2020
FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jul 2020
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Feb 2020
ZAP Surgical to Bring World-Class Brain Tumor Treatments to Rural German Hospital
Devices Oncology Neurosurgery
 HSMN NewsFeed - 9 Sep 2019
Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Aug 2018
OncoSec Appoints Alain Algazi, MD, as Clinical Strategic Advisor
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Aug 2018
Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI(TM) in combination with MEKTOVI(R) and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Jul 2018
The National Comprehensive Cancer Network (NCCN) Guidelines Recommend BRAFTOVI(TM) (encorafenib) in Combination with MEKTOVI(R) (binimetinib) as a Category 1 Treatment Option for Patients with Advanced BRAF-mutant Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2017
Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017
Devices Oncology
 HSMN NewsFeed - 26 May 2017
Elekta Radiosurgery Solutions Highlighted at International Stereotactic Radiosurgery Society Congress
Devices Oncology Surgery
 HSMN NewsFeed - 24 Apr 2017
Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Sep 2016
Varian Exhibiting New HyperArc Technology for High Definition Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 19 May 2016
Elekta Surpasses One Million Patients Treated with Leksell Gamma Knife
Devices Oncology Neurosurgery
 HSMN NewsFeed - 2 Nov 2015
New CyberKnife(R) and TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
Devices Oncology
 HSMN NewsFeed - 12 Oct 2015
Seven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System
Devices Neurosurgery Oncology
 HSMN NewsFeed - 18 Aug 2015
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 10 Apr 2015
Radius Health Today Announced That it Has Appointed Brent Hatzis-Schoch as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2014
Brainlab: First Patient Treatment with Revolutionary New Radiosurgery Software for Multiple Brain Metastases
Devices Oncology Neurosurgery
 HSMN NewsFeed - 30 Jul 2014
Study Shows that RapidArc(R) Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife(R) in the Treatment of Multiple Brain Metastases
Devices Oncology
 HSMN NewsFeed - 7 Jan 2014
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Nov 2013
Novocure Enrolls First Patients in a Randomized Trial of NovoTTF(TM) Therapy for Patients with Brain Metastases from Non-Small Cell Lung Cancer
Devices Oncology
 HSMN NewsFeed - 28 Aug 2013
First-ever Gamma Knife in Alaska Offers New Options for Treating Brain Cancer and Other Disorders
Devices Oncology
 HSMN NewsFeed - 25 Apr 2013
Elekta to Highlight Clinical and Safety Advantages of Gamma Knife Radiosurgery at 2013 AANS Meeting
Devices Neurosurgery Oncology
 HSMN NewsFeed - 11 Dec 2012
IsoRay's Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell and Barrow Neurological to The Society Of Neuro-Oncology
Devices Oncology
 HSMN NewsFeed - 11 Dec 2012
Diffusion Pharmaceuticals Receives FDA Orphan Designation for TSC, a First-in-Class Drug for the Treatment of Metastatic Brain Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Oct 2012
Elekta’s Growth Through Innovation to Increase Use of Radiation Therapy and Improve Lives of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 27 Sep 2012
Leading Cancer Center Uses High Intensity Mode on Varian TrueBeam Device to Deliver Precise Brain Radiosurgery
Devices Oncology
 HSMN NewsFeed - 16 Feb 2012
Radiosurgery Pioneer, University Hospital La Timone, Is World's First to Acquire Second Leksell Gamma Knife Perfexion
Devices Neurosurgery Oncology
 HSMN NewsFeed - 12 May 2011
Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
Devices Oncology
 HSMN NewsFeed - 10 May 2011
First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
Devices Oncology Neurosurgery
 HSMN NewsFeed - 30 Mar 2011
Study Shows Gamma Knife Radiosurgery for Patients With Multiple Brain Metastases is Best for Sparing Healthy Tissue
Devices Oncology Neurosurgery
 HSMN NewsFeed - 16 Aug 2010
Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Center's Installment of Elekta's Leksell Gamma Knife Perfexion
Devices Oncology
 HSMN NewsFeed - 1 Jul 2010
Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elekta's Leksell Gamma Knife Perfexion
Devices Oncology
 HSMN NewsFeed - 22 Dec 2009
University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System
Devices Oncology Neurosurgery
 HSMN NewsFeed - 18 Dec 2009
University of Virginia Acquires New Elekta Technology to Expand Patient Groups That Could Benefit From Gamma Knife Surgery
Devices Neurosurgery Oncology
 HSMN NewsFeed - 14 Dec 2009
Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments
Devices Oncology
 HSMN NewsFeed - 4 Nov 2009
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Oct 2009
Elekta's Radiosurgery Solutions on Center Stage at 2009 Congress of Neurological Surgeons Annual Meeting
Devices Oncology Neurosurgery FDA
 HSMN NewsFeed - 17 Sep 2009
Florida Clinicians Now Delivering Non-Invasive Image-Guided Treatments Using Novalis Tx(TM) Radiosurgery Technology
Devices Oncology
 HSMN NewsFeed - 1 Jul 2009
Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company
Biopharmaceuticals
 HSMN NewsFeed - 18 Jun 2009
Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
Devices Oncology
 HSMN NewsFeed - 26 Feb 2009
Elekta: New Treatment with Leksell Gamma Knife Perfexion Introduced in Japan
Devices Oncology
 HSMN NewsFeed - 25 Feb 2009
M. D. Anderson Cancer Center Acquires Leksell Gamma Knife Perfexion for Targeted Brain Lesion Treatments
Devices Oncology
 HSMN NewsFeed - 20 Oct 2008
Elekta Announces Installation of Leksell Gamma Knife(R) Perfexion(TM) at Haukeland University Hospital in Norway
Devices Oncology Neurosurgery
 HSMN NewsFeed - 2 Sep 2008
Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 24 Jul 2008
Three Novalis Tx(TM) Radiosurgery Platforms Ordered by Top Danish Cancer Hospital
Devices Oncology
 HSMN NewsFeed - 24 Jan 2008
Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
Devices Oncology
 HSMN NewsFeed - 21 Dec 2007
Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Dec 2007
GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2007
Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
Devices Oncology
 HSMN NewsFeed - 23 Oct 2007
NCCN Updates Central Nervous System Cancers Guidelines
Devices Oncology
 HSMN NewsFeed - 19 Sep 2007
Pharmacyclics Announces Addition of Robert W. Duggan to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2007
Varian Medical Systems and BrainLAB Join Forces to Introduce Novalis Tx(R) - the World's Most Powerful and Versatile Stereotactic Radiosurgery System
Devices Oncology
 HSMN NewsFeed - 5 Sep 2007
Pharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R) in Recurrent Non-Small Cell Lung Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2007
Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
Devices Neurosurgery Oncology
 HSMN NewsFeed - 24 Aug 2007
Genentech Announces Resubmission of Supplemental Biologics License Application for Avastin in Combination with Paclitaxel for First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Aug 2007
Cancer 'Warrior' Chooses Gamma Knife(R) Surgery
Devices Oncology
 HSMN NewsFeed - 30 Jul 2007
Gamma Knife(R) Surgery Best Choice, Says Cancer Patient
Devices Oncology Neurosurgery
 HSMN NewsFeed - 26 Jul 2007
Visualase, Inc. Announces Successful Completion of First Six Clinical Procedures with Its Image-Guided Thermal Therapy System for Treatment of Brain Metastases
Devices Oncology Neurosurgery Interventional
 HSMN NewsFeed - 26 Jun 2007
As Medical Radiation Exposure Rises, Lowering Peripheral Dose from Radiosurgery Takes on New Importance
Devices Oncology Neurosurgery
 HSMN NewsFeed - 18 Jun 2007
Leksell Gamma Knife(R) Perfexion(TM) Setting New Standards for Fast, Effective, Precise Radiosurgery Treatments
Devices Oncology
 HSMN NewsFeed - 4 Jun 2007
Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine(R) (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Glaxosmithkline Reports Positive New Data on Tykerb(R)(Lapatinib) at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2007
Pharmacyclics Announces Positive Final Results of Phase 2 Trial of Xcytrin(R) Plus Radiosurgery for Brain Metastases With Occult Tumors Detected in 24% of Patients
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 2 May 2007
Elekta Receives Order to Deliver the First Leksell Gamma Knife(R) Perfexion(TM) to India
Devices Neurosurgery Oncology
 HSMN NewsFeed - 30 Apr 2007
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
Devices Neurosurgery Oncology
 HSMN NewsFeed - 23 Apr 2007
Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin(R) Injection to Treat Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Apr 2007
Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission
Biopharmacetuicals Oncology Regulatory
 HSMN NewsFeed - 16 Apr 2007
Elekta Initiatives Will Increase Access to Gamma Knife(R) Surgery, the Gold Standard in Radiosurgery
Devices Oncology Neurosurgery
 HSMN NewsFeed - 10 Apr 2007
Leading China Cancer Center Offers Advanced Radiotherapy Treatments Using Varian's On-Board Imager
Devices Oncology
 HSMN NewsFeed - 4 Apr 2007
Pharmacyclics' Xcytrin New Drug Application for Treatment of Lung Cancer Brain Metastases to Be Filed Over Protest
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastatic Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2007
Allos Therapeutics Appoints Pablo J. Cagnoni, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Feb 2007
Pharmacyclics Receives Refuse to File Letter for Xcytrin
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2007
Europe's First Trilogy Tx System to Offer New Hope for Irish Cancer Patients
Devices Oncology
 HSMN NewsFeed - 8 Jan 2007
Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 Trial of Its Novel Antifolate PDX in Patients With Peripheral T-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Dec 2006
Pharmacyclics Submits New Drug Application for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Nov 2006
Pharmacyclics Announces Presentation of Pooled Analysis of Xcytrin(R) for Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Nov 2006
Pharmacyclics Announces Presentation of Preliminary Results From Phase 2 Clinical Trial of Xcytrin(R) With Radiosurgery for Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Nov 2006
Updated Analysis Demonstrates Long-Term Survival Benefit of EFAPROXYN(TM) in Treating NSCLC Patients Receiving Sequential Chemoradiotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Oct 2006
Brain Surgery at its Most Precise: Leksell Gamma Knife(R) Perfexion(TM), from Elekta, Provides New Levels of Patient Comfort and Physician Convenience
Devices Neurosurgery
 HSMN NewsFeed - 3 Oct 2006
Allos Therapeutics Receives FDA Fast Track Designation for PDX for the Treatment of T-cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 May 2006
Genentech Submits Supplemental Biologics License Application for Avastin With Chemotherapy in First-Line Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 May 2006
GlaxoSmithKline Demonstrates Progress of Oncology Portfolio; New Data to Be Presented at ASCO 2006
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2006
Elekta Convenes 300 Neurosurgeons, Radiation Oncologists and Leksell Gamma Knife(R) Users in Seoul, Korea
Devices Oncology Neurosurgery
 HSMN NewsFeed - 9 May 2006
Pharmacyclics to Submit New Drug Application for Xcytrin(R) for Treatment of Lung Cancer Patients With Brain Metastases
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 63

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 63 additional stories matching:
brain metastases
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.